Skip to main content

Branded

  • Aralez completes acquisition of U.S. rights to Toprol-XL, authorized generic

    MISSISSAUGA, Ontario — Specialty pharmacy company Aralez Pharmaceuticals on Monday announced the completion of its acquisition of the U.S. rights to AstraZeneca’s extended-release beta blocker, Toprol-XL (metoprolol succinate) and its authorized generic. Aralez paid $175 million at closing. 
     
  • 'Spread Hope, Not the Flu' campaign raises $1.8 million for Rite Aid's KidCents

    CAMP HILL, Pa. - The Rite Aid Foundation announced this week that it is donating more than $1.8 million to KidCents charities on behalf of Rite Aid customers who received a flu shot this year. Each of the more than 360 KidCents charities, located in communities served by Rite Aid, will receive a $5,000 grant to support programs that improve the health and well-being of children in their communities.

  • FDA approves Allergan’s Restasis Multidose

    SILVER SPRING, Md. — The Food and Drug Administration has approved Allergan’s Restasis Multidose, (cyclosporine ophthalmic emulsion 0.05%), the company announced Friday. The approval brings a new delivery system for the company’s eye drops, which are approved to help patients with chronic dry eye produce more of their own tears. 
     
  • Astellas to acquire Ganymed

    TOKYO and MAINZ, Germany — In a move that would expand its oncology pipeline, Astellas Pharma announced Friday its agreement to acquire Ganymed Pharmaceuticals for €422 million, or about $461 million. 
     
    Under the agreement, Astellas would acquire 100% of the equity in Ganymed and Ganymed shareholders will be able to receive up to €860 million in further contingent payments tied to the progress of Ganymed’s most advanced clinical program, IMAB362. Ganymed would become a wholly owned subsidiary of Astellas. 
  • Astellas USA Foundation appoints new president

    NORTHBROOK, Ill. — Astellas USA Foundation on Wednesday announced that it had named a new president. Moyra Knight, a member of the foundation's advisory committee, will take the helm, succeeding outgoing president Jeffrey Winton, who has led the organization since 2014. Winton will continue his role as Astellas SVP corporate affairs. 
     
  • Teva, IBM expand Watson Health Cloud collaboration

    LAS VEGAS — In a move aimed at addressing the two challenges of discovering new options for treatment and improving chronic disease management, Teva and IBM on Wednesday announced an expansion of their e-health alliance, with both projects running on the IBM Watson Health Cloud. 
     
  • Pennsylvania Bio renames as Life Sciences Pennsylvania

    PHILADELPHIA — The statewide trade organization for life sciences company in Pennsylvania, which has been named Pennsylvania Bio, announced Wednesday that it would be changing its name and brand. 
     
X
This ad will auto-close in 10 seconds